Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taliglucerase alfa extension in Gaucher disease
NCT01422187Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2011
- Primary completion
- May 2014
- Modality
- Replacement Enzymes
01
Overview
A Phase 3 trial of taliglucerase alfa in Gaucher disease (GD), sponsored by Pfizer. Started Aug 2011; status: completed.
02
Drugs
taliglucerase alfa
03
Conditions
Gaucher disease (GD)
Beyond the preview
Go deeper on NCT01422187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422187.